In Q3-2023, One Immunology BU launched revolutionary concepts to drive focus on key business priorities per TA to accelerate patients’ recruitment, utilizing GEMINI mindset under the overarching strategic initiatives of Control Rheum, Guard Gastro, and Drive Derm
We're excited to showcase the revitalization of neuroscience & PAH unit.It has undergone a remarkable transformation, this rejuvenation started during our cycle meeting, where we redefined success and emphasized the importance of happy hearts and strong minds . We've held various activities in both the private and public sectors, Together, we're shaping a future defined by innovation, resilience, and remarkable achievements in the fields of neuroscience & PAH.
In Q3 2023 we started the launch of Gemini & Q3 marked as the highest sales in Onco-Hema history & highest acceleration in patient’s recruitment ever. This achievement was mainly driven by 3 strategic pillars: Maximize Zytiga & Imbruvica ,Unlock the access for Erleada & Darzalex &Drive Balversa forward